분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-04-02 18:57:14 , Hit : 1035
 GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID

April 01, 2016, 10:26:00 AM EDT By RTT News


(RTTNews.com) - GlaxoSmithKline (GSK, GSK.L) announced that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA, in conjunction with the Committee for Advanced Therapies or CAT, has issued a positive opinion recommending marketing authorisation for Strimvelis to treat patients with a very rare disease called ADA-SCID or severe combined immunodeficiency due to adenosine deaminase deficiency.

The medicine is a stem cell gene therapy created for an individual patient from their own cells which is intended to correct the root cause of the disease. If approved by the European Commission, the medicine - currently known as GSK2696273 (autologous CD34+ cells transduced to express ADA) - will be commercialised under the brand name Strimvelis, for the treatment of patients with ADA-SCID for whom no suitable human leukocyte antigen (HLA)-matched related stem cell donor is available.

The gene therapy for the treatment of ADA-SCID was originally developed by Ospedale San Raffaele (OSR) and Fondazione Telethon (Telethon), through their joint San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) and was taken forward by GSK through a strategic collaboration formed in 2010 between GSK, OSR and Telethon.


Read more: http://www.nasdaq.com/article/gsk-gets-positive-chmp-opinion-for-strimvelis-to-treat-rare-disease-adascid-20160401-00467#ixzz44f5JneSs







947   바이오통신원 [바이오토픽] 이제는 염기편집 시대, Cas9를 변형하여 DNA 한 글자만 바꾼다.  이성욱 2016/04/21 1171
946   Hitting HIV with CRISPR/Cas9 Can Arouse Resistance  이성욱 2016/04/10 865
  GSK Gets Positive CHMP Opinion For Strimvelis To Treat Rare Disease ADA-SCID  이성욱 2016/04/02 1035
944   CRISPR Can Tag RNA  이성욱 2016/03/26 800
943   미니멀세포(minimal cell)를 만든 크레이그 벤터  이성욱 2016/03/26 956
942   Minimal Genome Created  이성욱 2016/03/26 832
941   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 774
940   RNA May Surpass DNA in Precision Medicine  이성욱 2016/03/23 821
939   Zika Update  이성욱 2016/03/15 755
938   CRISPR/Cas9을 이용하여 PRRS 바이러스에 감염되지 않는 돼지를 개발하다  이성욱 2016/03/14 1203
937   유전자 가위, 매머드 복원-안전한 백신의 시대 리본 자르다  이성욱 2016/03/14 987
936   Tunable Form of CRISPR Is an Efficient Regulator of Stem Cell Expression  이성욱 2016/03/14 700
935   NIH 연구진들은 5가지 종류의 암에서 공유되는 충격적인 게놈 상의 특징을 확인  이성욱 2016/03/09 829
934   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1049
933   CRISPR Editing of Human Embryos Approved in the U.K.  이성욱 2016/02/02 807
932   CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 762
931   거대 바이러스에게서도 발견된 CRISPR 유사 시스템  이성욱 2016/03/02 1123
930   MIT 선정 2015년 주목받은 Biomedicine 뉴스  이성욱 2016/02/03 888
929   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1065
928   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1057

[이전 10개] [1]..[11][12][13][14][15][16] 17 [18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN